title: Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients.
authors.forename: Chun
authors.initials: C
authors.lastname: Yang
authors.forename: Zhi-qiang
authors.initials: ZQ
authors.lastname: Zhou
authors.forename: Zhi-qin
authors.initials: ZQ
authors.lastname: Gao
authors.forename: Jin-yun
authors.initials: JY
authors.lastname: Shi
authors.forename: Jian-Jun
authors.initials: JJ
authors.lastname: Yang
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000097:blood / Q000188:drug therapy; D015852:Eukaryotic Initiation Factor-2 / Q000097:blood*; D038362:Glycogen Synthase Kinase 3 / Q000097:blood*; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*; D008297:Male; D010766:Phosphorylation / Q000187:drug effects; D020123:Sirolimus / Q000097:blood*; D013997:Time Factors; D055815:Young Adult
chemical_list: D000928:Antidepressive Agents; D015852:Eukaryotic Initiation Factor-2; D007649:Ketamine; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3; D020123:Sirolimus